Journals / Retina-Vitreus / 2000 / Cilt: 8 - Sayı: 1

Retinal venous obstructions associated with anticardiolipin antibodies

Antikardiolipin antikorlarının retinal ven tıkanıklıkları ile ilişkisi

Pages
40–45
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: There was no significant relation between ACA levels and RVO, so there is no need for systematic screening of these antibodies in patients with RVO, routinely.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In recent years, a relation between high levels of anticardiolipin antibodies (ACA) and recurrent venous and arterial thrombotic complications has been shown.
📊
Key Findings & Data:Material and method: A sample of 47 patients with RVO (34 branch RVO, 13 central RVO) and 29 subject as a control group were studied.
💡
Conclusion & Impact:Conclusion: There was no significant relation between ACA levels and RVO, so there is no need for systematic screening of these antibodies in patients with RVO, routinely.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:IgG · ELISA · IgM

Abstract

Objective: In recent years, a relation between high levels of anticardiolipin antibodies (ACA) and recurrent venous and arterial thrombotic complications has been shown. In this study, we aimed to determine whether there was a relation between retinal venous obstruction (RVO) and ACA. Material and method: A sample of 47 patients with RVO (34 branch RVO, 13 central RVO) and 29 subject as a control group were studied. The control group was matched for age and systemic-diseases to the patient group. Samples obtained from each group were assessed for Ig G and Ig M ACA by Enzyme-Linked Immunoabsorbant assay (ELISA). Results: Ig G ACA was positive (>10 GPL U/ml), in 21.8% and 24.1 and Ig M ACA was positive (>7 MPL U/ml) in 12.7% and 13.8% of patients and controls groups, respectively. There was no significant important difference between patients and control groups in Ig ACA and Ig M ACA positivity (p>0.05). Conclusion: There was no significant relation between ACA levels and RVO, so there is no need for systematic screening of these antibodies in patients with RVO, routinely.

Özet

Amaç: Son yıllarda antikardiolipin antikor (AKA) düzeyindeki yükselme ile tekrarlayan venöz ve arteriyel trombotik komplikasyonlar arasında bir ilişki olduğu gösterilmiştir. Bu çalışmada retinal ven tıkanıklığı olan olguların antikardiolipin antikorları ile ilişkisinin ortaya konulması amaçlanmıştır. Materyal ve Metot: Çalışma grubuna retinal ven tıkanıklığı olan 47 hasta (34 dal, 13 santral retinal ven tıkanıklığı ) ve yaş grupları benzer olan 29 olgu kontrol grubu olarak alındı. Ig G ve Ig M antikardiolipin antikorları ELISA yöntemi ile ölçülüp hastalar ile kontrol grubu karşılaştırıldı. Bulgular: Ig G AKA; hastalarda %21.8, kontrol grubunda %24.1 pozitif (>10 GPL U/ml) bulundu. Ig M AKA; hastalarda %12.7, kontrol grubunda %13.8 pozitif (>7 MPL U/ml) olarak tespit edildi. Yapılan istatistiki analizde Ig G ve IG M antikardiolipin antikorlarında retinal ven tıkanıklığı olan hastalar ile kontrol grubu arasında anlamlı farklılık tespit edilmedi (p >0.05). Sonuç: Antikardiolipin antikor düzeyi ile retinal ven tıkanıklığı arasında anlamlı ilişki bulunmamıştır ve bu hastalarda rutin olarak tetkik edilmesine gerek yoktur.

🔖

Cite This Article

BİRİNCİ, H., BİRİNCİ, A., DURUPINAR, B., KAMAN, A., ÖGE, İ. (2000). Retinal venous obstructions associated with anticardiolipin antibodies. Retina-Vitreus, Cilt: 8 - Sayı: 1, 40–45. https://ajindex.com/articles/305391

References (11)

  1. Wine AK, Şamama MM: The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions. Survey of ophthalmology 1993,37 (4):283-92
  2. Levine SR, Welch KM A: The spectrum of neurologic disease associated with antiphospholipid antibodies, lupus anticoagulant and anticardiolipin antibody. Arch. Neurol. 1987,44:876-83
  3. Harris EN, Gharavi AE, Boey ML, Patel BM, et al: Anticardiolipin antibodies antibodies:Detection by radyoimmunoassay and association with thrombosis in systemic lupus erythematosus. The Lancet 1983, 26:1211-14 4. Ginsburg KS, Liang MH, Newcomer L, Goldhaber SZ, et al: Anticardiolipin antibodies and the risk for ıschemic stroke and venous thrombosis. Annals of Int. Med. 1992,117:997-1002
  4. Briley DP, Coull BM, Goodnight SH: Neurological disease associated with antiphospholipid antibodies. Annals of Neurology 1989,25(3):221-27 6. Bernard A, Bayani N, Chretien N, Cochard C et al: Antiphospholipid antibodies in retinal vascular occlusions. Arch. Ophthalmol. 1994,112:790-95
  5. Cerda C, Neira O, Palma S, Abumohor P. Et al: Anticardiolipin antibodies in connective tissue diseases. Rev. Med. Chil. 1992,120(3):239-43 8. Cid MC, Cervera R, Font J, Lopez SA, et al: Late thrombotic events in patients with temporal arteritis and anticardiolipin antibodies. Clin. Exp. Rheumatol. 1990, 8(4)359-63 9. Özdemir Y, Önder F, Yarangümeli A, Küçükkuyumcu C ve ark: Behçet hastalığındaki retinal vasküler komplikasyonların antikardiyolipin antikorları ile ilişkisi. MN Oftalmoloji 1996,3(2): 150-4
  6. Bertram B, Haase G, Remky A, Reim M: Anticardiolipin antibodies in vascular occlusions of the eye. Opthalmologe 1994,91(6):768-71
  7. Finazzi G, Brancaccio V, Moia M, Ciavarella N ve ark. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the italian registry. The Am J Medicine 1996;100:530-36
  8. Klok AM, Geertzen R, Rothova A, et al. Anticardiolipin antibodies in uveitis. Curr Eye Res. 1992; 11:209
  9. Bleil L, Manger B, Winkler TH, et al. The role of antineutrophil cytoplasm antibodies, anticardiolipin antibodies, von Willebrand factor antigen, and fibronectin for the diagnosis of systemic vasculitis. J Rheumatol. 1991;18:1119
  10. Zaman AG, Khamashta MA, Graham EM: Anticardiolipin antibodies in isolated retinal vasculitis. Am. J. Ophthalmol. 1993,116(6):769-70
  11. Greenfield SM, Teare JP, Whitehead MW, Thompson RP: Amaurosis fugax, Chron's